Trial Profile
A Phase I Study of Oral Fluoropyrimidine Capecitabine (Xeloda Roche) Combined With Intravenous Cisplatin in Patients With Advanced Cancer of the Digestive System.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin
- Indications Advanced breast cancer; Cancer; Digestive system neoplasms; Gastrointestinal cancer; Head and neck cancer; Lung cancer
- Focus Adverse reactions
- 25 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2005 New trial record.